6-[6-[3-(1-cyclopropylethylamino)pyrrolidin-1-yl]pyridazin-3-yl]-2-methyl-1,3-benzoxazol-5-ol
C21H25N5O2 — CID 167504054
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[6-[3-(1-cyclopropylethylamino)pyrrolidin-1-yl]pyridazin-3-yl]-2-methyl-1,3-benzoxazol-5-ol
6-[6-[3-(1-cyclopropylethylamino)pyrrolidin-1-yl]pyridazin-3-yl]-2-methyl-1,3-benzoxazol-5-ol (PubChem CID 167504054) has the molecular formula C21H25N5O2 and a molecular weight of 379.46 g/mol. Its IUPAC name is 6-[6-[3-(1-cyclopropylethylamino)pyrrolidin-1-yl]pyridazin-3-yl]-2-methyl-1,3-benzoxazol-5-ol.
Molecular Properties
| Compound Name | 6-[6-[3-(1-cyclopropylethylamino)pyrrolidin-1-yl]pyridazin-3-yl]-2-methyl-1,3-benzoxazol-5-ol |
|---|---|
| PubChem CID | 167504054 |
| Molecular Formula | C21H25N5O2 |
| Molecular Weight | 379.46 g/mol |
| Exact Mass | 379.20 |
| IUPAC Name | 6-[6-[3-(1-cyclopropylethylamino)pyrrolidin-1-yl]pyridazin-3-yl]-2-methyl-1,3-benzoxazol-5-ol |
| SMILES | Cc1nc2cc(O)c(-c3ccc(N4CCC(NC(C)C5CC5)C4)nn3)cc2o1 |
| InChI | InChI=1S/C21H25N5O2/c1-12(14-3-4-14)22-15-7-8-26(11-15)21-6-5-17(24-25-21)16-9-20-18(10-19(16)27)23-13(2)28-20/h5-6,9-10,12,14-15,22,27H,3-4,7-8,11H2,1-2H3 |
| InChIKey | VXJANQPKVLJQGQ-UHFFFAOYSA-N |
| XLogP | 3.27 |
| TPSA | 87.31 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 379.46 |
| LogP ≤ 5 | 3.27 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167504054 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.